文献速递胃肠外科围术期管理与 ERAS

腹腔镜翻修食管旁疝修补术:单中心16年经验

Laparoscopic revision paraesophageal hernia repair: a 16-year experience at a single institution.
PubMed 文献 · Surg Endosc · 2022-06-17

末次随访RSI评分较基线显著改善46.4%(p<0.001),总复发率16.3%,仅6.3%需再次手术翻修。

要点

  • 腹腔镜翻修PEHr并发症率15.8%、死亡率1.1%,30天再入院率9.5%
  • 末次随访RSI评分较基线显著改善46.4%(p<0.001)
  • 总复发率16.3%,仅6.3%需再次手术翻修

核心结论

  • 腹腔镜翻修食管旁疝修补术并发症率和死亡率低,可改善生活质量,但长期抗反流药物使用率高。
  • 复发率仍较低,仅少数患者需第二次翻修,但需更长随访明确长期复发率和症状改善。

研究设计与样本

  • 疝类型为II型49.5%、III型46.3%、IV型4.2%;68.7%行完全胃底折叠,27.7%行部分胃底折叠,14.7%行Collis胃成形术。
  • 中位随访17.6个月,使用经验证的RSI和GERD-HRQL问卷评估生活质量,采用单变量分析。

主要发现

  • 总体并发症率15.8%,死亡率1.1%,30天再入院率9.5%。
  • 末次随访时47.9%患者仍使用抗反流药物。
  • 末次随访平均RSI评分较基线显著改善46.4%(p<0.001)。
  • 仅有初次修补史与有翻修史的患者在末次随访时生活质量无显著差异。
  • 总复发率16.3%,其中6.3%需手术翻修。

临床怎么用

  • 对于症状性复发性食管旁疝,腹腔镜翻修手术可作为治疗选择,围术期风险可接受。
  • 术后需关注长期抗反流药物使用,近半数患者末次随访仍在用药。
  • 翻修术后生活质量可获改善,但应告知患者复发及再次翻修的可能性。

局限性

  • 回顾性单中心设计。
  • 中位随访仅17.6个月,长期复发率和症状改善需更长随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laparoscopic paraesophageal hernia repair (PEHr) is a safe and effective procedure for relieving foregut symptoms associated with paraesophageal hernias (PEH). Nonetheless, it is estimated that about 30-50% of patients will have symptomatic recurrence requiring additional surgical intervention. Revision surgery is technically demanding and may be associated with a higher rate of morbidity and poor patient-reported outcomes. We present the largest study of perioperative and quality-of-life outcomes among patients who underwent laparoscopic revision PEHr. METHODS: A retrospective review of all patients who underwent laparoscopic revision paraesophageal hernia repair between February 2003 and October 2019, at a single institution was conducted. All revisions of Type I hiatal hernias were excluded. The following validated surveys were used to evaluate quality-of-life outcomes: Reflux Symptom Index (RSI) and Gastroesophageal Reflux Disease Health-Related QOL (GERD-HRQL). Patient demographic, perioperative, and quality-of-life (QOL) data were analyzed using univariate analysis. RESULTS: One hundred ninety patients were included in the final analysis (63.2% female, 90.5% single revision, 9.5% multiple revisions) with a mean age, BMI, and age-adjusted Charlson score of 56.6 ± 14.7 years, 29.7 ± 5.7 kg/m2, and 2.04 ± 1.9, respectively. The study cohort consisted of type II (49.5%), III (46.3%), and IV hiatal hernia (4.2%), respectively. Most patients underwent either a complete (68.7%) or partial (27.7%) fundoplication. A Collis gastroplasty was performed in 14.7% of patients. The median follow-up was 17.6 months. The overall morbidity and mortality rate were 15.8% and 1.1%, respectively. The 30-day readmission rate was 9.5%. Additionally, at latest follow-up 47.9% remained on antireflux medication. At latest follow-up, there was significant improvement in mean RSI score (46.4%, p < 0.001) from baseline within the study population. Furthermore, there was no significant difference in QOL between patients who had a history of an initial repair only or history of revision surgery at latest review. The overall recurrence rate was 16.3% with 6.3% requiring a surgical revision. CONCLUSION: Laparoscopic revision PEHr is associated with a low rate of morbidity and mortality. Revision surgery may provide improvement in QOL outcomes, despite the high rate of long-term antireflux medication use. The rate of recurrent paraesophageal hernia remains low with few patients requiring a second revision. However, longer follow-up is needed to better characterize the long-term recurrence rate and symptomatic improvements.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Addo A, Carmichael D, Chan K, et al. Laparoscopic revision paraesophageal hernia repair: a 16-year experience at a single institution. Surg Endosc. 2022. PMID: 35713721. doi:10.1007/s00464-022-09359-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。